Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125549072 | 12554907 | 2 | F | 2016 | 20160815 | 20160713 | 20160819 | EXP | US-AMGEN-USASP2016088948 | AMGEN | 53.00 | YR | A | F | Y | 68.27000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125549072 | 12554907 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 125549072 | 12554907 | 2 | SS | XELJANZ XR | TOFACITINIB CITRATE | 1 | Unknown | 11 MG, UNK | 0 | 11 | MG | TABLET | |||||||
| 125549072 | 12554907 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125549072 | 12554907 | 4 | C | PREMPRO | ESTROGENS, CONJUGATEDMEDROXYPROGESTERONE ACETATE | 1 | Oral | UNK, QD | 0 | TABLET | QD | ||||||||
| 125549072 | 12554907 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | CAPSULE | QD | ||||||
| 125549072 | 12554907 | 6 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 125549072 | 12554907 | 7 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | Oral | 100 MG, AS NEEDED | 0 | 100 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125549072 | 12554907 | 1 | Rheumatoid arthritis |
| 125549072 | 12554907 | 2 | Product used for unknown indication |
| 125549072 | 12554907 | 3 | Product used for unknown indication |
| 125549072 | 12554907 | 5 | Gastrooesophageal reflux disease |
| 125549072 | 12554907 | 6 | Depression |
| 125549072 | 12554907 | 7 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125549072 | 12554907 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125549072 | 12554907 | Drug ineffective | |
| 125549072 | 12554907 | Dyspepsia | |
| 125549072 | 12554907 | Hypersensitivity | |
| 125549072 | 12554907 | Mobility decreased | |
| 125549072 | 12554907 | Pain | |
| 125549072 | 12554907 | Rheumatoid arthritis | |
| 125549072 | 12554907 | Swelling | |
| 125549072 | 12554907 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125549072 | 12554907 | 2 | 2016 | 0 |